Danish drugmaker Novo Nordisk launched Ozempic in India at $24.35 per week for the 0.25 mg dose, following regulatory approval in September.

#NVO #Ozempic #NVOStock #NVONews #NovoNordisk #NovoNordiskStock #NovoNordiskNews #OzempicIndia #GLP1India #Semaglutide #SemaglutideIndia #GLP1
$NVO